apoE4 allosteric modulators (E-Scape Bio)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameapoE4 allosteric modulators (E-Scape Bio)
Drug Alias NameAlzheimer's Disease/ApoE4 Program 1 (E-Scape Bio)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein E4 modulators
TargetsApolipoprotein E4
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesE-Scape Bio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesE-Scape Bio
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A